Mounting concerns over government's drug-related policies

Pharmaceutical business sources say that a series of drug-related policies designed to discourage the use of high-priced drugs, such as minimum actually transacted pricing system, drug pricing re-evaluation system and feasibility assessment system for proper use of insurance drugs, are merely intended for cutting the reimbursement prices without tangible outcomes and this will result in further...